FilingFirehose · free AI preview
MADRIGAL PHARMACEUTICALS, INC.
MDGL · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 2
Types: Officer Departure
Madrigal Pharmaceuticals has filed two officer departure notices in the past 90 days (April and June 2026), both tagged as Item 5.02 events. The company shows no detected cyber incidents during this window, but leadership transitions warrant closer examination alongside broader corporate governance trends. The full $49 Report adds detailed 8-K context for each departure, a 12-month filing history to establish whether turnover is accelerating, dilution risk scoring, and AI-flagged risk signals across the firm's recent disclosures and financing activity.
Want the full 5-section $49 Report on MDGL?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.